We are live on ! Find out more
INBS icon

Intelligent Bio Solutions
INBS

1 hedge funds and large institutions have $8.44K invested in Intelligent Bio Solutions in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

24.56% less ownership

Funds ownership: 24.69% → 0.13% (-25%)

75% less funds holding

Funds holding: 4 → 1 (-3)

100% less capital inflows, than outflows

Capital inflows: $346 | Capital outflows: $643K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
1
Holders Change
-3
Holders Change %
-75%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$346

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$367K
2
Walleye Capital
Walleye Capital
New York
-$274K
3
UBS Group
UBS Group
Switzerland
-$1.78K

INBS Hedge Fund Activity: Q2 2023 in Review

1 of the 6,390 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q2 2023, worth a combined $8.44K — down 99% from $651K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of INBS and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Tower Research Capital (TRC), adding an estimated $346. The largest seller was Sabby Management, exiting entirely with an estimated $367K sold.

  • 1 institutional investor held Intelligent Bio Solutions (INBS) as of Q2 2023, down from 4 in Q1 2023.
  • Funds reported $8.44K of Intelligent Bio Solutions stock for Q2 2023, down 99% quarter-over-quarter.
  • 0 funds opened new Intelligent Bio Solutions positions in Q2 2023 and 3 closed out, a net change of -3 holders.
  • The largest Intelligent Bio Solutions buyer in Q2 2023 was Tower Research Capital (TRC), an estimated $346 added.
  • The largest Intelligent Bio Solutions seller in Q2 2023 was Sabby Management, an estimated $367K sold.

Based on aggregated 13F filings for Q2 2023.